{
    "2018-04-04": [
        [
            {
                "time": "",
                "original_text": "绩优+创新！医药行业妖股频出，这两点值得一看",
                "features": {
                    "keywords": [
                        "绩优",
                        "创新",
                        "医药行业",
                        "妖股"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "港股半日总结：恒指倒跌22点，腾讯偏软，医药股逆势扬",
                "features": {
                    "keywords": [
                        "港股",
                        "恒指",
                        "倒跌",
                        "腾讯",
                        "医药股",
                        "逆势扬"
                    ],
                    "sentiment_score": -0.3,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "午评：恒指跌0.08%企稳30000点 医药股集体大涨",
                "features": {
                    "keywords": [
                        "恒指",
                        "跌",
                        "企稳",
                        "医药股",
                        "集体大涨"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "上海医药升幅扩至9% 内地将落实税收优惠",
                "features": {
                    "keywords": [
                        "上海医药",
                        "升幅",
                        "税收优惠"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "中药板块防御性凸显 低估值股或迎修复机会",
                "features": {
                    "keywords": [
                        "中药板块",
                        "防御性",
                        "低估值",
                        "修复机会"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "中药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "仿制药政策框架明晰 进口替代的大周期开启（附股）",
                "features": {
                    "keywords": [
                        "仿制药",
                        "政策框架",
                        "进口替代",
                        "大周期"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "仿制药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "国务院发文力促仿制药研发 进口替代大周期开启（附股）",
                "features": {
                    "keywords": [
                        "国务院",
                        "仿制药",
                        "研发",
                        "进口替代",
                        "大周期"
                    ],
                    "sentiment_score": 0.95,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "仿制药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "医疗保健行业热点速评：国务院出台相关意见 进一步支持国产优质仿制药",
                "features": {
                    "keywords": [
                        "医疗保健",
                        "国务院",
                        "仿制药",
                        "支持"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "仿制药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "中药板块逆势上涨防御性凸显 5只成长股被低估受关注",
                "features": {
                    "keywords": [
                        "中药板块",
                        "逆势上涨",
                        "防御性",
                        "低估",
                        "成长股"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "中药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}